The industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape - Italy”. The report is an essential source of
information and analysis on Italy’s healthcare, regulatory and reimbursement
landscape. It identifies the key trends in the healthcare market and provides
insights into the demographic, regulatory and reimbursement landscape and the
country’s healthcare infrastructure. Most importantly, it provides valuable
insights into the trends and segmentation of the Italian pharmaceutical and
medical device markets. The report is built using data and information sourced
from proprietary databases.
Get Sample Report @ https://www.wiseguyreports.com/sample-request/472484-countryfocus-healthcare-regulatory-and-reimbursement-landscape-italy
Italy’s population was 61.78 million in 2015, and is
increasing due to a positive balance between the birth and death rates, as well
as through immigration. The country’s policymakers are currently faced with the
challenge of an increasing unemployment rate due to a lack of clear monetary
policies. The pharmaceutical market at the consumer price level (including
Value Added Tax (VAT) and excluding hospital sales) was estimated at $22
billion in 2015, and is expected to decline to approximately $18 billion by
2020, at a negative Compound Annual Growth Rate (CAGR) of 3.3%. The medical
devices market was estimated at approximately $13.2 billion in 2015, and is
expected to reach $16.2 billion by 2020, at a CAGR of 4.2%. The decline of
Italy’s pharmaceutical market can primarily be attributed to -
- Owing to government measures to decrease healthcare
expenditure
- Falling sales of patented drugs,
- Price cuts for drugs
- Government initiatives to promote generics
- The strict pricing of drugs through negotiations and
through external reference pricing and internal reference pricing
Scope
The report provides information on Italy’s healthcare,
regulatory and reimbursement landscape, and includes -
- An overview of the pharmaceutical and medical devices
markets, comprising size, segmentation and key drivers and barriers
- Profiles and SWOT analyses of the major players in the
pharmaceutical and medical devices market. The major players covered for the
pharmaceutical market are Menarini, Angelini, Chiesi, Bracco and Recordati. The
major players covered for the medical devices market are DePuy Synthes,
GlaxoSmithKline (GSK), Baxter, Essilor and Siemens Healthcare
- An insightful review of the country’s reimbursement and
regulatory landscape, including details of the healthcare reimbursement
process, regulatory agencies and approval processes for new drugs
- Detailed analysis of the political and economic
environment, including economic indicators, demographics, and healthcare
infrastructure and expenditure
- An overview of the opportunities for and challenges to
growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by
allowing you to -
- Develop business strategies by understanding the trends
shaping and driving Italy’s healthcare market
- Drive revenues by understanding the key trends,
reimbursement and regulatory policies, pharmaceutical market segments and
companies likely to impact Italy’s healthcare market in the future
- Formulate effective sales and marketing strategies by
understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying
the market categories and segments that present the most opportunities for
consolidation, investment and strategic partnership
Table of
Contents
1 Table of Contents 7
1.1 List of Tables
11
1.2 List of
Figures 15
2 Introduction 20
2.1 GlobalData
Report Guidance 20
3 Overview of
Pharmaceutical and Medical Device Markets 21
3.1 Pharmaceutical
Market 21
3.1.1 Market
Overview 21
3.1.2 Pharmaceutical
Import and Export 23
3.1.3 Supply
Channels 25
3.1.4 Market
Segments 26
3.1.5 Major
Therapeutic Areas 31
3.1.6 Major
Companies 34
3.2 Medical Device
Market 74
3.2.1 Market
Overview 74
3.2.2 Overview of
Top Five Segments 76
3.2.3 Diagnostic
Market 87
3.2.4 Major
Companies 89
3.3 Market Drivers
and Barriers 125
3.3.1 Drivers
125
3.3.2 Barriers
127
4 Market Access 130
4.1 Reimbursement
and Payer Landscape 130
4.1.1 Overview
of Healthcare system 130
4.1.2 Evolution
of Healthcare System in Italy 135
4.1.3
Reimbursement Process 138
4.1.4 Overview
of Insurance Providers 144
4.1.5 Patient
Share in Healthcare Spending 146
4.1.6 Price
Trends in the Healthcare Sector 149
4.1.7 Pricing
Policies 150
4.2 Regulatory
Landscape 152
4.2.1 Overview
of Regulatory Agencies 152
4.2.2 Market
Authorization Procedure for Pharmaceutical Products 153
4.2.3 New Medical
Device Approval Process 166
4.2.4 Licensing
Process for Pharmaceutical and Medical Device Manufacturing 170
4.2.5
Intellectual Property Rights 173
4.2.6 Clinical
Trial Regulations 176
4.2.7
Pharmaceutical Advertising Regulations 180
4.2.8 Pharmacy
Regulations 183
4.2.9 Labeling
and Packaging Regulations 184
5 Country Analysis
187
5.1 Political
Environment 187
5.1.1 Political
Structure 187
5.1.2 Analysis
of the Current Political Environment 193
5.1.3 Healthcare
Policy Initiatives 195
5.2 Economic
Landscape 196
5.3 Economic
Indicators 199
5.3.1 Gross
Domestic Product 199
5.3.2 Gross
National Income 203
Access Report @ https://www.wiseguyreports.com/reports/472484-countryfocus-healthcare-regulatory-and-reimbursement-landscape-italy
Contact Info:
NORAH TRENT
Partner Relations
& Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Get
in touch:
LinkedIn:
www.linkedin.com/company/4828928
Twitter:
https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
No comments:
Post a Comment